Leukemia Research
Volume 33, Issue 2 , Pages 222-231 , February 2009

A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome

Received 10 April 2008 ,Revised 26 June 2008 ,Accepted 4 August 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(08)00363-9

doi: 10.1016/j.leukres.2008.08.004

Leukemia Research
Volume 33, Issue 2 , Pages 222-231 , February 2009

Article Tools

* Image Usage & Resolution